Pepscan

About Pepscan

Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate customers in the development and manufacturing of peptides. At its end-to-end facility in Lelystad, the Netherlands, Pepscan offers a range of patented technologies, phage display capabilities, a lead-optimization array platform, and production facilities for R&D- to GMP-grade peptides, including libraries and neoantigen vaccines. Among its patents is the CLIPS technology, which locks peptides into active conformations. With its epitope mapping service platform, Pepscan also supports biotech companies in developing their antibody pipelines. The underlying protein mimicry platform delivers binding insights, even in cases where other technologies fall short.

Keywords

• Cell Penetrating Peptides
• Clinical Peptides
• Clips Phage Display
• Custom Peptide Synthesis
• Discontinuous Epitope Mapping
• Disuplhide-Rich Peptides
• Fluorescently Labeled Peptides
• Gmp Peptides
• Neoantigen
• Peptide Antigens
• Peptide Discovery
• Peptide Libraries
• Peptide Modifications
• Personalized Medicine
• Precision Epitope Mapping
• Radio-Labeling Of Peptides
• Stable Isotope Peptides
• T-Cell Epitope Mapping
• Therapeutic Peptides

Address

• Headquarters

  Zuidersluisweg 28243RC LelystadFlevoland, Netherlands

Team by function

Based on 2 public job profiles as of 3 September 2026.

• Research / R&D1
• Sales1